Hiv/aids news and hiv/aids widget

GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based biotechnology company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, announced today that the launch of its Phase 2a Human Vaccine Trials will take place in twelve sites across North and South America. These trials are conducted in collaboration with The National Institutes of health (NIH), and the HIV Vaccine Trials Network (HVTN).

America's pharmaceutical research companies are testing 109 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA). December 1 marks the 20th anniversary of "World AIDS Day" - a global awareness campaign that originated at the 1988 World Summit of Ministers of health on Programmes for AIDS Prevention.

As part of the Dec. 1 observance of World AIDS Day, Acting Secretary of health Everette James today urged Pennsylvanians to be tested for HIV - the virus that causes AIDS. He also highlighted ongoing efforts to educate the public about the disease and how it is prevented. "Our message is clear: regardless of your personal background, age, ethnicity or race, being tested for HIV is the only sure way to know your status and to protect your health," said James.

In a year that sees the election of a new US President, the theme of World AIDS Day 2008 is "leadership". Continuing the theme from 2007, the leadership theme encourages...

An article in this week's PLoS medicine describes the African AIDS Vaccine Programme (AAVP), which was established in 2000. The AAVP is a network of African HIV vaccine stakeholders, led by Africans across the continent, with a vision of "an AIDS-free Africa through an effective vaccine.

On this 1 December, the 20th Anniversary of World AIDS Day, World AIDS Campaign wish to extend their congratulations to the newly appointed UNAIDS Executive Director Michel Sidibé. In accepting his new position, Mr. Sidibé said that, "We have to ensure that there is strong and long term leadership and financial commitment to respond to AIDS that is grounded in evidence and human rights." In light of the 2008 World AIDS Day theme of leadership we commend Mr.

Treatments have come far BUT research shows that one third of people living with HIV in London have been discriminated against and many are living in poverty. Too many people with HIV are still facing high levels of social and economic hardship, argues Professor Jonathan Elford of City University London.

With World AIDS Day on December 1, a leading expert is urging the government to repeat the 1980s campaigns in order to deal with a new crisis of awareness and understanding of the AIDS threat in the UK.

On the 20th anniversary of World AIDS Day on Dec. 1, advocates worldwide discussed numerous challenges facing HIV prevention efforts and called on governments to follow through on pledges to support HIV/AIDS care, prevention and treatment, AFP/Yahoo! News reports.

The number of HIV/AIDS cases in Asia could reach 10 million by 2010 -- more than double current estimates -- unless countries take increased action to curb the spread of the disease, health officials said on Friday at the launch of an online database on HIV/AIDS in the Asia-Pacific region, AFP/Google.com reports. The database -- available at